 Biologic Excipients Market Insights, Competitive Landscape, and Market Forecast - 2033
The global biologic excipients market is poised for consistent growth, driven by the expanding role of biologics in modern healthcare. The market is expected to increase from 1.6 billion in 2026 to... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global biologic excipients market is poised for consistent growth, driven by the expanding role of biologics in modern healthcare. The market is expected to increase from 1.6 billion in 2026 to 2.1 billion by 2033, registering a compound annual growth rate of 4.20% over the forecast period. Biologic excipients are vital formulation components that support the stability, safety, and performance of biologic drugs, including monoclonal antibodies, vaccines, and recombinant proteins. As biologics become increasingly central to therapeutic innovation, the demand for specialized excipients continues to rise steadily.Market Insights Biologic excipients are uniquely designed to meet the complex requirements of biologic formulations, which are highly sensitive to physical and chemical changes. These excipients play a crucial role in maintaining protein structure, preventing degradation, and enhancing drug delivery efficiency. The market is characterized by stringent regulatory standards and a growing emphasis on product quality and consistency. The shift toward advanced biologic therapies, including personalized medicine and targeted treatments, is significantly influencing the market landscape. Pharmaceutical companies are increasingly investing in innovative formulation approaches, which require high-performance excipients. Additionally, the rapid growth of biosimilars is contributing to market expansion, as manufacturers seek reliable and cost-effective excipient solutions to ensure product equivalence and stability. Drivers The strong growth of the biopharmaceutical sector remains a key driver for the biologic excipients market. An increasing number of biologic drugs are entering development pipelines and receiving regulatory approvals, driving demand for excipients that can ensure product integrity and effectiveness. These excipients are essential for protecting biologic molecules from environmental stress and maintaining therapeutic efficacy. Rising global demand for vaccines and immunotherapies is another significant growth factor. Increased focus on disease prevention and treatment has led to higher production volumes of vaccines, which rely on specialized excipients for stability and storage. Furthermore, the growing prevalence of chronic diseases such as cancer and autoimmune disorders is accelerating the adoption of biologic treatments. Advancements in pharmaceutical technology are also supporting market growth. The development of novel excipients and improved formulation techniques is enabling more efficient drug delivery systems, including sustained-release and injectable biologics, thereby increasing the overall demand for excipients. Business Opportunity The biologic excipients market presents a wide range of growth opportunities for industry participants. The expanding biosimilars market is creating strong demand for cost-effective and high-quality excipient solutions, encouraging innovation among manufacturers. Companies that focus on developing multifunctional and customized excipients are likely to gain a competitive advantage. Emerging markets are offering additional opportunities due to increasing investments in healthcare infrastructure and local pharmaceutical manufacturing. As these regions strengthen their biopharmaceutical capabilities, the need for advanced excipients is expected to grow. Strategic collaborations between excipient manufacturers and biopharmaceutical companies are becoming more prominent, facilitating innovation and accelerating product development timelines. The increasing trend of outsourcing to contract research and manufacturing organizations is also opening new avenues for excipient suppliers to expand their reach and capabilities. Region Analysis North America dominates the biologic excipients market, supported by a highly developed biopharmaceutical industry, strong research and development activities, and advanced healthcare infrastructure. The presence of leading market players further strengthens the region’s position. Europe represents a significant share of the market, driven by increasing adoption of biosimilars and a strong regulatory framework that emphasizes product quality and safety. Continued innovation in pharmaceutical manufacturing is also supporting market growth in the region. Asia Pacific is expected to witness rapid growth due to expanding pharmaceutical production, rising healthcare investments, and increasing awareness of biologic therapies. Countries such as China and India are emerging as key contributors, driven by favorable government policies and growing biotechnology sectors. Latin America and the Middle East and Africa are gradually expanding, supported by improving healthcare access and rising demand for advanced therapies. Although these regions currently hold smaller market shares, they offer promising growth potential over the forecast period. Key Players • Merck KGaA • BASF SE • Evonik Industries AG • Roquette Frères • DFE Pharma • Clariant • Colorcon • Croda International Plc • Avantor Inc. • Pfanstiehl Inc. • Spectrum Chemical Manufacturing Corp. • Associated British Foods plc • Ashland Global Holdings Inc. • Actylis • JRS Pharma GmbH & Co. KG Segmentation By Excipient Type: • Polymers • Sugar Alcohols • Polysorbates • Inorganic Salts • Amino Acids • Surfactants • Others By End User: • Biopharmaceutical Manufacturers • Contract Research Organizations • Contract Manufacturing Organizations • Research Organizations By Region: • North America • Latin America • Europe • Asia Pacific • Middle East and Africa Table of Contents1. Executive Summary1.1. Global Biologic Excipients Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Biologic Excipients Market Outlook, 2020-2033 3.1. Global Biologic Excipients Market Outlook, by Excipient Type, Value (US$ Bn), 2020-2033 3.1.1. Polymers 3.1.2. Sugar Alcohols 3.1.3. Polysorbates 3.1.4. Inorganic Salts 3.1.5. Amino Acids 3.1.6. Surfactants 3.1.7. Others 3.2. Global Biologic Excipients Market Outlook, by End User, Value (US$ Bn), 2020-2033 3.2.1. Biopharmaceutical Manufacturers 3.2.2. Contract Research Organizations 3.2.3. Contract Manufacturing Organizations 3.2.4. Research Organizations 3.3. Global Biologic Excipients Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Latin America 3.3.5. Middle East & Africa 4. North America Biologic Excipients Market Outlook, 2020-2033 4.1. North America Biologic Excipients Market Outlook, by Excipient Type, Value (US$ Bn), 2020-2033 4.1.1. Polymers 4.1.2. Sugar Alcohols 4.1.3. Polysorbates 4.1.4. Inorganic Salts 4.1.5. Amino Acids 4.1.6. Surfactants 4.1.7. Others 4.2. North America Biologic Excipients Market Outlook, by End User, Value (US$ Bn), 2020-2033 4.2.1. Biopharmaceutical Manufacturers 4.2.2. Contract Research Organizations 4.2.3. Contract Manufacturing Organizations 4.2.4. Research Organizations 4.3. North America Biologic Excipients Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.3.1. U.S. Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 4.3.2. U.S. Biologic Excipients Market Outlook, by End User, 2020-2033 4.3.3. Canada Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 4.3.4. Canada Biologic Excipients Market Outlook, by End User, 2020-2033 4.4. BPS Analysis/Market Attractiveness Analysis 5. Europe Biologic Excipients Market Outlook, 2020-2033 5.1. Europe Biologic Excipients Market Outlook, by Excipient Type, Value (US$ Bn), 2020-2033 5.1.1. Polymers 5.1.2. Sugar Alcohols 5.1.3. Polysorbates 5.1.4. Inorganic Salts 5.1.5. Amino Acids 5.1.6. Surfactants 5.1.7. Others 5.2. Europe Biologic Excipients Market Outlook, by End User, Value (US$ Bn), 2020-2033 5.2.1. Biopharmaceutical Manufacturers 5.2.2. Contract Research Organizations 5.2.3. Contract Manufacturing Organizations 5.2.4. Research Organizations 5.3. Europe Biologic Excipients Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.3.1. Germany Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 5.3.2. Germany Biologic Excipients Market Outlook, by End User, 2020-2033 5.3.3. Italy Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 5.3.4. Italy Biologic Excipients Market Outlook, by End User, 2020-2033 5.3.5. France Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 5.3.6. France Biologic Excipients Market Outlook, by End User, 2020-2033 5.3.7. U.K. Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 5.3.8. U.K. Biologic Excipients Market Outlook, by End User, 2020-2033 5.3.9. Spain Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 5.3.10. Spain Biologic Excipients Market Outlook, by End User, 2020-2033 5.3.11. Russia Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 5.3.12. Russia Biologic Excipients Market Outlook, by End User, 2020-2033 5.3.13. Rest of Europe Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 5.3.14. Rest of Europe Biologic Excipients Market Outlook, by End User, 2020-2033 5.4. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Biologic Excipients Market Outlook, 2020-2033 6.1. Asia Pacific Biologic Excipients Market Outlook, by Excipient Type, Value (US$ Bn), 2020-2033 6.1.1. Polymers 6.1.2. Sugar Alcohols 6.1.3. Polysorbates 6.1.4. Inorganic Salts 6.1.5. Amino Acids 6.1.6. Surfactants 6.1.7. Others 6.2. Asia Pacific Biologic Excipients Market Outlook, by End User, Value (US$ Bn), 2020-2033 6.2.1. Biopharmaceutical Manufacturers 6.2.2. Contract Research Organizations 6.2.3. Contract Manufacturing Organizations 6.2.4. Research Organizations 6.3. Asia Pacific Biologic Excipients Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.3.1. China Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 6.3.2. China Biologic Excipients Market Outlook, by End User, 2020-2033 6.3.3. Japan Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 6.3.4. Japan Biologic Excipients Market Outlook, by End User, 2020-2033 6.3.5. South Korea Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 6.3.6. South Korea Biologic Excipients Market Outlook, by End User, 2020-2033 6.3.7. India Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 6.3.8. India Biologic Excipients Market Outlook, by End User, 2020-2033 6.3.9. Southeast Asia Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 6.3.10. Southeast Asia Biologic Excipients Market Outlook, by End User, 2020-2033 6.3.11. Rest of SAO Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 6.3.12. Rest of SAO Biologic Excipients Market Outlook, by End User, 2020-2033 6.4. BPS Analysis/Market Attractiveness Analysis 7. Latin America Biologic Excipients Market Outlook, 2020-2033 7.1. Latin America Biologic Excipients Market Outlook, by Excipient Type, Value (US$ Bn), 2020-2033 7.1.1. Polymers 7.1.2. Sugar Alcohols 7.1.3. Polysorbates 7.1.4. Inorganic Salts 7.1.5. Amino Acids 7.1.6. Surfactants 7.1.7. Others 7.2. Latin America Biologic Excipients Market Outlook, by End User, Value (US$ Bn), 2020-2033 7.2.1. Biopharmaceutical Manufacturers 7.2.2. Contract Research Organizations 7.2.3. Contract Manufacturing Organizations 7.2.4. Research Organizations 7.3. Latin America Biologic Excipients Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.3.1. Brazil Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 7.3.2. Brazil Biologic Excipients Market Outlook, by End User, 2020-2033 7.3.3. Mexico Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 7.3.4. Mexico Biologic Excipients Market Outlook, by End User, 2020-2033 7.3.5. Argentina Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 7.3.6. Argentina Biologic Excipients Market Outlook, by End User, 2020-2033 7.3.7. Rest of LATAM Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 7.3.8. Rest of LATAM Biologic Excipients Market Outlook, by End User, 2020-2033 7.4. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Biologic Excipients Market Outlook, 2020-2033 8.1. Middle East & Africa Biologic Excipients Market Outlook, by Excipient Type, Value (US$ Bn), 2020-2033 8.1.1. Polymers 8.1.2. Sugar Alcohols 8.1.3. Polysorbates 8.1.4. Inorganic Salts 8.1.5. Amino Acids 8.1.6. Surfactants 8.1.7. Others 8.2. Middle East & Africa Biologic Excipients Market Outlook, by End User, Value (US$ Bn), 2020-2033 8.2.1. Biopharmaceutical Manufacturers 8.2.2. Contract Research Organizations 8.2.3. Contract Manufacturing Organizations 8.2.4. Research Organizations 8.3. Middle East & Africa Biologic Excipients Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.3.1. GCC Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 8.3.2. GCC Biologic Excipients Market Outlook, by End User, 2020-2033 8.3.3. South Africa Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 8.3.4. South Africa Biologic Excipients Market Outlook, by End User, 2020-2033 8.3.5. Egypt Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 8.3.6. Egypt Biologic Excipients Market Outlook, by End User, 2020-2033 8.3.7. Nigeria Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 8.3.8. Nigeria Biologic Excipients Market Outlook, by End User, 2020-2033 8.3.9. Rest of Middle East Biologic Excipients Market Outlook, by Excipient Type, 2020-2033 8.3.10. Rest of Middle East Biologic Excipients Market Outlook, by End User, 2020-2033 8.4. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Merck KGaA 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. BASF SE 9.4.3. Evonik Industries AG 9.4.4. Roquette Frères 9.4.5. DFE Pharma 9.4.6. Clariant 9.4.7. Colorcon 9.4.8. Croda International Plc 9.4.9. Avantor Inc. 9.4.10. Pfanstiehl Inc. 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Fairfield Market Research社の 医薬品・バイオテクノロジー分野 での最新刊レポート
本レポートと同じKEY WORD（landscape）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
